Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial
After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial
After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial
Submitted by
admin
on September 18, 2017 - 9:43am
Source:
Xconomy
News Tags:
Rodin Therapeutics
Biogen
Alzheimer's disease
clinical trials
Headline:
After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial
Do Not Allow Advertisers to Use My Personal information
